Elixxer Ltd.
ELIXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $106 | $77 | $92 | $164 |
| SG&A Expenses | $121 | $90 | $92 | $164 |
| Sales & Mktg Exp. | $15 | $13 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $121 | $90 | $92 | $164 |
| Operating Income | -$121 | -$90 | -$92 | -$164 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$652 | -$530 | -$453 | -$1,413 |
| Pre-Tax Income | -$773 | -$619 | -$545 | -$1,577 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$773 | -$619 | -$545 | -$1,577 |
| % Margin | – | – | – | – |
| EPS | -0.07 | -0.029 | -0.05 | -0.14 |
| % Growth | -139.7% | 41.6% | 64.3% | – |
| EPS Diluted | -0.07 | -0.029 | -0.05 | -0.14 |
| Weighted Avg Shares Out | 11,339 | 11,339 | 11,339 | 11,339 |
| Weighted Avg Shares Out Dil | 11,339 | 11,339 | 11,339 | 11,339 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $569 | $532 | $499 | $481 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$204 | -$88 | -$46 | -$1,095 |
| % Margin | – | – | – | – |